journal
https://read.qxmd.com/read/38652827/in-vitro-evaluation-of-the-carcinogenic-potential-of-perfluorinated-chemicals
#1
JOURNAL ARTICLE
Monica Vaccari, Stefania Serra, Andrea Ranzi, Federico Aldrovandi, Giangabriele Maffei, Maria G Mascolo, Ada Mescoli, Elisa Montanari, Gelsomina Pillo, Francesca Rotondo, Ivan Scaroni, Lorenzo Vaccari, Cristina Zanzi, Tony Fletcher, Martin Paparella, Annamaria Colacci
Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) are the major components of long-chain per- and polyfluorinated alkyl substances (PFAS), known for their chemical stability and environmental persistence. Even if PFOA and PFOS have been phased out or are limited in use, they still represent a concern for human and environmental health. Several studies have been performed to highlight the toxicological behavior of these chemicals and their mode of action (MoA). Data suggested the causal association between PFOA or PFOS exposure and carcinogenicity in humans, but the outcomes of epidemiological studies showed some inconsistency...
April 22, 2024: ALTEX
https://read.qxmd.com/read/38641922/characterization-and-optimization-of-variability-in-a-human-colonic-epithelium-culture-model
#2
JOURNAL ARTICLE
Colleen M Pike, Bailey Zwarycz, Bryan E McQueen, Mariana Castillo, Catherine Barron, Jeremy M Morowitz, James A Levi, Dhiral Phadke, Michele Balik-Meisner, Deepak Mav, Ruchir Shah, Danielle L Cunningham Glasspoole, Ron Laetham, William Thelin, Maureen K Bunger, Elizabeth M Boazak
Animal models have historically been poor preclinical predictors of gastrointestinal (GI) directed therapeutic efficacy and drug-induced GI toxicity. Human stem and primary cell-derived culture systems are a major focus of efforts to create biologically relevant models that enhance preclinical predictive value of intestinal efficacy and toxicity. The inherent variability in stem-cell-based cultures makes development of useful models a challenge; the stochastic nature of stem-cell differentiation interferes with the ability to build and validate reproducible assays that query drug responses and pharmacokinetics...
April 18, 2024: ALTEX
https://read.qxmd.com/read/38579692/revolutionizing-developmental-neurotoxicity-testing-a-journey-from-animal-models-to-advanced-in-vitro-systems
#3
JOURNAL ARTICLE
Lena Smirnova, Helena T Hogberg, Marcel Leist, Thomas Hartung
Developmental neurotoxicity (DNT) testing has seen enormous progress over the last two decades. Preceding even the publication of the animal-based OECD test guideline for DNT testing in 2007, a series of non-animal technology workshops and conferences (starting in 2005) shaped a community that has delivered a comprehensive battery of in vitro test methods (IVB). Its data interpretation is covered by a very recent OECD test guidance (No. 377). Here, we aim to overview the progress in the field, focusing on the evolution of testing strategies, the role of emerging technologies, and the impact of OECD test guidelines on DNT testing...
April 6, 2024: ALTEX
https://read.qxmd.com/read/38501278/phase-out-planning-for-animal-experimentation
#4
JOURNAL ARTICLE
Anne Gourmelon, Philippe Hubert, Elise Grignard, Lisa Baumann, Sharon Munn, Cécile Michel
The 4th Annual Forum on Endocrine Disrupters organized by the European Commission brought together authors of this article around the topic: "From bench to validated test guidelines: (pre)validation of test methods". Validation activities are meant to demonstrate the relevance and reliability of methods and approaches used in regulatory safety testing. These activities are essential to facilitate regulatory use, still they are largely underfunded and unattractive to the scientific community. In the last decade, there has been large amounts of funding invested in European research towards the development of approaches that can be used in regulatory decision-making, including for the identification of endocrine disrupters...
March 19, 2024: ALTEX
https://read.qxmd.com/read/38492209/have-the-non-technical-summaries-of-animal-experiments-in-europe-improved-an-update
#5
JOURNAL ARTICLE
Katy Taylor, Tilo Weber, Laura Rego Alvarez
Following a review of the Directive 2010/63/EU on the protection of animals used for scientific purposes in the European Union (EU), non-technical project summaries (NTS) of all approved projects must be published in a central database using a standard template. Our initial review of the NTS reported in ALTEX in 2018 had found the NTS to be deficient in their accessibility and quality, notably the adverse effects section where the harms to the animals are meant to be described. Here we repeat our review to see if these legislative changes have improved the accessibility and quality of the NTS...
March 14, 2024: ALTEX
https://read.qxmd.com/read/38430006/phase-out-planning-for-animal-experimentation
#6
JOURNAL ARTICLE
Nico Müller
Since the late 2010s, the idea of phase-out planning for animal experimentation (PPAE) has come to the foreground of political debates, but central notions and arguments are understood differently by different participants and stand in need of clarification. This article draws on public communications on ten political projects related to PPAE to propose a philosophical explication of PPAE and to articulate proponents' central moral argument. According to the argument, the phase-out of animal experimentation is morally desirable and planned interventions are both necessary and sufficient to achieve it...
March 1, 2024: ALTEX
https://read.qxmd.com/read/38429992/risk-based-prioritization-of-pfas-using-phenotypic-and-transcriptomic-data-from-human-induced-pluripotent-stem-cell-derived-hepatocytes-and-cardiomyocytes
#7
JOURNAL ARTICLE
Han-Hsuan D Tsai, Lucie C Ford, Zunwei Chen, Allison N Dickey, Fred A Wright, Ivan Rusyn
Per- and polyfluoroalkyl substances (PFAS) are chemicals with important applications; they are persistent in the environment and may pose human health hazards. Regulatory agencies are considering restrictions and bans of PFAS; however, little data exists for informed decisions. Several prioritization strategies were proposed for evaluation of potential hazards of PFAS. Structure-based grouping could expedite the selection of PFAS for testing; still, the hypothesis that structure-effect relationships exist for PFAS requires confirmation...
February 22, 2024: ALTEX
https://read.qxmd.com/read/38376873/qualitative-and-quantitative-concentration-response-modelling-of-gene-co-expression-networks-to-unlock-hepatotoxic-mechanisms-for-next-generation-chemical-safety-assessment
#8
JOURNAL ARTICLE
Steven J Kunnen, Emma Arnesdotter, Christian Tobias Willenbockel, Mathieu Vinken, Bob van de Water
Next generation risk assessment of chemicals revolves around the use of mechanistic information without animal experimentation. In this regard, toxicogenomics has proven to be a useful tool to elucidate the underlying mechanisms of adverse effects of xenobiotics. In the present study, two widely used human in vitro hepatocyte culture systems, namely primary human hepatocytes (PHH) and human hepatoma HepaRG cells, were exposed to liver toxicants known to induce liver cholestasis, steatosis or necrosis. Benchmark concentration-response modelling was applied to transcriptomics gene co-expression networks (modules) to derive benchmark concentrations (BMCs) and to gain mechanistic insight into the hepatotoxic effects...
February 20, 2024: ALTEX
https://read.qxmd.com/read/38414285/heads-on-designing-a-qualification-framework-for-organ-on-chip
#9
JOURNAL ARTICLE
Monica Piergiovanni, Milena Mennecozzi, Stavroula Sampani, Maurice Whelan
No abstract text is available yet for this article.
January 23, 2024: ALTEX
https://read.qxmd.com/read/38215352/the-probable-future-of-toxicology-probabilistic-risk-assessment
#10
JOURNAL ARTICLE
Alexandra Maertens, Eric Antignac, Emilio Benfenati, Denise Bloch, Ellen Fritsche, Sebastian Hoffmann, Joanna Jaworska, George Loizou, Kevin McNally, Przemyslaw Piechota, Erwin L Roggen, Marc Teunis, Thomas Hartung
Both because of the shortcomings of existing risk assessment methodologies, as well as newly available tools to predict hazard and risk with machine learning approaches, there has been an emerging emphasis on probabilistic risk assessment. Increasingly sophisticated AI models can be applied to a plethora of exposure and hazard data to obtain not only predictions for particular endpoints but also to estimate the uncertainty of the risk assessment outcome. This provides the basis for a shift from deterministic to more probabilistic approaches but comes at the cost of an increased complexity of the process as it requires more resources and human expertise...
January 12, 2024: ALTEX
https://read.qxmd.com/read/38634448/indian-society-for-alternatives-to-animal-experiments-sixth-annual-meeting-and-international-conference
#11
EDITORIAL
Syed Z Rahman, Alam Anam, Ankita Pandey, Rohit Bisht, Mohammad A Akbarsha
No abstract text is available yet for this article.
2024: ALTEX
https://read.qxmd.com/read/38629803/60-years-of-the-3rs-symposium-lessons-learned-and-the-road-ahead
#12
JOURNAL ARTICLE
Michael Balls, Rolf Bass, Rodger Curren, Julia Fentem, Alan Goldberg, Thomas Hartung, Kathrin Herrmann, Nicole C Kleinstreuer, Lisa Libowitz, John Parascandola, Andrew Rowan, Horst Spielmann, Martin L Stephens, Russell S Thomas, Katya Tsaioun
When The Principles of Humane Experimental Technique was published in 1959, authors William Russell and Rex Burch had a modest goal: to make researchers think about what they were doing in the laboratory - and to do it more humanely. Sixty years later, their groundbreaking book was celebrated for inspiring a revolution in science and launching a new field: The 3Rs of alternatives to animal experimentation. On November 22, 2019, some pioneering and leading scientists and researchers in the field gathered at the Johns Hopkins Bloomberg School of Public Health in Bal-timore for the 60 Years of the 3Rs Symposium: Lessons Learned and the Road Ahead...
2024: ALTEX
https://read.qxmd.com/read/38626317/3-days-for-3rs-2023-refinement-reduction-replacement
#13
JOURNAL ARTICLE
Augusto Vitale, Maurilio Calleri, Francesca Caloni, Cristina M Failla, Paola Granata, Laura Gribaldo, Urte Jaeh, Michela Kuan, Stefano Lorenzetti, Francesco Nevelli, Giulia Ranaldi, Irene Ruspantini, Orsola R Salva, Lena Smirnova, Julia Steitz, Luigia Trabace, Zoe Windsor, Isabella De Angelis
No abstract text is available yet for this article.
2024: ALTEX
https://read.qxmd.com/read/38207287/elements-and-development-processes-for-test-methods-in-toxicology-and-human-health-relevant-life-science-research
#14
EDITORIAL
Eike Cöllen, Yaroslav Tanaskov, Anna-Katharina Holzer, Michelle Dipalo, Jasmin Schäfer, Udo Kraushaar, Marcel Leist
Many laboratory procedures generate data on properties of chemicals, but they cannot be equated with toxicological "test methods". This apparent discrepancy is not limited to in vitro testing, using animal-free new approach methods (NAM), but also applies to animal-based testing approaches. Here, we give a brief overview of the differences between data generation and the setup or use of a complete test method. While there is excellent literature available on this topic for specialists (GIVIMP guidance; ToxTemp overview), a brief overview and easily-accessible entry point may be useful for a broader community...
2024: ALTEX
https://read.qxmd.com/read/38204181/summer-school-for-systematic-reviews-of-animal-studies-fostering-evidence-based-and-rigorous-animal-research
#15
JOURNAL ARTICLE
Marianna Rosso, Simona E Doneva, David W Howells, Cathalijn Hc Leenaars, Benjamin V Ineichen
No abstract text is available yet for this article.
2024: ALTEX
https://read.qxmd.com/read/38197568/editorial
#16
EDITORIAL
Sonja von Aulock
No abstract text is available yet for this article.
2024: ALTEX
https://read.qxmd.com/read/38196320/no-more-monkey-business-advancing-personalized-medicine-with-animal-free-research-animalfree-research-forum-2023
#17
JOURNAL ARTICLE
Miriam A Zemanova, Silvia Frey
No abstract text is available yet for this article.
2024: ALTEX
https://read.qxmd.com/read/38194639/elements-and-development-processes-for-test-methods-in-toxicology-and-human-health-relevant-life-science-research
#18
JOURNAL ARTICLE
Alexandra Maertens, Thomas Luechtefeld, Jean Knight, Thomas Hartung
Green toxicology is marching chemistry into the 21st century. This emerging framework will transform how chemical safety is evaluated by incorporating evaluation of the hazards, exposures, and risks associated with chemicals into early product development in a way that minimizes adverse impacts on human and environmental health. The goal is to minimize toxic threats across entire supply chains through smarter designs and policies. Traditional animal testing methods are replaced by faster, cutting-edge innovations like organs-on-chips and artificial intelligence predictive models that are also more cost-effective...
2024: ALTEX
https://read.qxmd.com/read/38048429/protectiveness-of-nam-based-hazard-assessment-which-testing-scope-is-required
#19
JOURNAL ARTICLE
Walter Zobl, Annette Bitsch, Jonathan Blum, Jan J W A Boei, Liliana Capinha, Giada Carta, Jose Castell, Enrico Davoli, Christina Drake, Ciaran P Fisher, Muriel M Heldring, Barira Islam, Paul Jennings, Marcel Leist, Damiano Pellegrino-Coppola, Johannes P Schimming, Kirsten E Snijders, Laia Tolosa, Bob van de Water, Barbara M A van Vugt-Lussenburg, Paul Walker, Matthias M Wehr, Lukas S Wijaya, Sylvia E Escher
Hazard assessment (HA) requires toxicity tests to allow deriving protective points of departure (PoDs) for risk assessment irrespective of a compound's mode of action (MoA). The scope of in vitro test batteries (ivTB) thereby necessitated for systemic toxicity is still unclear. We explored the protectiveness regarding systemic toxicity of an ivTB with a scope, which was guided by previous findings from rodent studies, where examining six main targets, including liver and kidney, was sufficient to predict the guideline scope-based PoD with high probability...
December 4, 2023: ALTEX
https://read.qxmd.com/read/38043132/toward-implementing-virtual-control-groups-in-nonclinical-safety-studies
#20
JOURNAL ARTICLE
Emily Golden, David Allen, Alexander Amberg, Lennart T Anger, Elizabeth Baker, Szczepan W Baran, Frank Bringezu, Matthew Clark, Guillemette Duchateau-Nguyen, Sylvia E Escher, Varun Giri, Armelle Grevot, Thomas Hartung, Dean Dingzhou Li, Wolfgang Muster, Kevin Snyder, Ronald Wange, Thomas Steger-Hartmann
Historical data from control groups in animal toxicity studies is currently mainly used for comparative purposes to assess validity and robustness of study results. Due to the highly controlled environment in which the studies are performed and the homogeneity of the animal collectives it has been proposed to use the historical data for building so-called virtual control groups, which could replace partly or entirely the concurrent control. This would constitute a substantial contribution to the reduction of animal use in safety studies...
December 1, 2023: ALTEX
journal
journal
34982
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.